MEIS1 functions as a tumor suppressor to inhibit CRC cell growth and tumor formation by suppressing DNA damage repair and increasing the sensitivity to oxaliplatin (Li et al. 2022). This evidence concerns the gene MEIS1 and colorectal carcinoma.